The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients.
about
The Role of Autophagy-Related Proteins in Candida albicans InfectionsPerformance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.Incidence of invasive aspergillosis following remission-induction chemotherapy for acute leukemia: a retrospective cohort study in a single Canadian tertiary care centreFirst detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment.Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational sEpidemiology of invasive fungal infections in the mediterranean areaComparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year periodGalactomannan Testing and the Incidence of Invasive Pulmonary Aspergillosis: A 10-Year Nationwide Population-Based Study in Taiwan.Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis.Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study).Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species.SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients.Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive Aspergillosis.Phylogenetic relationships matter: antifungal susceptibility among clinically relevant yeasts.Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations.Triazole antifungal agents in invasive fungal infections: a comparative review.The risk of infections in patients with myelodysplastic syndromes in 2016.Serious fungal diseases in the Republic of Uzbekistan.Serious fungal infections in Peru.Serious fungal infections in Thailand.Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status.Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases.An estimate of the burden of serious fungal diseases in Greece.European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies.Epidemiology and clinical characteristics of invasive mould infections: A multicenter, retrospective analysis in five Asian countries.Burden of serious fungal infections in Nepal.Caspofungin Treatment of Aspergillus fumigatus Results in ChsG-Dependent Upregulation of Chitin Synthesis and the Formation of Chitin-Rich Microcolonies.Burden of serious fungal infections in Ukraine.The burden of serious fungal diseases in Russia.Burden of serious fungal infections in Belgium.Infectious Disease. How to bolster the antifungal pipeline.Infectious complications in chronic lymphocytic leukemia.Clinical outcome and prognostic factors associated with invasive pulmonary aspergillosis: An 11-year follow-up report from Taiwan.An invisible threat: mutation-mediated resistance to triazole drugs in Aspergillus.Burden of Serious Fungal Infections in Jordan.The importance of risk factors for the prediction of patients with invasive pulmonary aspergillosis.Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies.An Estimate of Severe and Chronic Fungal Diseases in the Republic of Kazakhstan.
P2860
Q26752567-EB9720BD-0B45-48BC-A0E6-3DB7E101B10DQ33703531-96F216C4-0DA1-4CDD-94CF-D4E3EE25B5D3Q33964833-AEFF1212-349C-49CE-98DB-891FDFD58B54Q34057414-942FA880-DB92-4654-9DE9-46AF494F2925Q34288593-C5E2F460-231A-48AA-8B3B-8AF00671C3A1Q35010686-05B26EB5-8295-4E99-A892-25FD19DF757CQ35794484-908FC7FA-70E1-4162-BE51-766865242B9BQ35930362-C230BA78-1A84-4E5C-8DC3-C97B0603B525Q36216209-DB446680-F5F2-4699-8158-755D59734E11Q36715906-A5C44B2A-BF80-4EEF-A817-8FF19A2C0C44Q37480190-8051A835-B512-42D7-AF25-CA450C32C17AQ37530914-8D790C71-5F92-402A-88FB-8B33A826EBF6Q37562454-B3EB4799-721B-4C45-9D29-2CEDBB093427Q37643638-97D8A49D-E38F-4F3E-AF7A-42DA11C50A99Q37918556-1EA20388-6EA8-4778-8211-D7E1644BA41FQ37964703-7CA7A9D2-A5EC-48CE-95D4-8D22FFA48BE9Q38813702-A4FCF236-F994-4348-9419-390BF8922B68Q38907928-2139D92A-17CB-4535-A05E-29F3396A200CQ38927025-B0F798FB-66F6-428D-9960-9DD5F338C5D1Q38940722-3FF8D776-D569-4A71-A207-8977FE89AF96Q39062930-E2588233-0DE9-420F-A08E-AF3DCC37B435Q39367515-26AE28C5-CECB-48A2-9944-4206F5BD340CQ39845050-D16C0A75-A01C-4D61-A864-4AE8098D86ABQ40034587-83CD69B1-701D-4788-BF2F-F8C75002E67DQ40194293-07B12EF9-A9D4-4EC8-BDED-0F30A61C0D7AQ40451800-36A9501E-F463-4356-BB58-8E51A2F02F6FQ40743249-E2481091-EC0B-4BB7-BCDD-BEB4F4B9D639Q40960949-77CE5128-1EBC-4E27-930D-E84D968DC483Q40960976-2DE71C45-2EB3-440F-8E04-89B943DBA25AQ40961016-5D223B7D-5277-4DE5-8CAE-63B9A9635D61Q41378447-5844C394-D66E-4C52-BB21-671D8CB4BF04Q42277456-E717C078-C5CB-4164-9967-2E226DB539D0Q43017782-F3BFEB2C-1B81-408E-9926-E796DA57EC41Q47149131-0E47FA6E-3CF3-4514-9DB7-846E6F61D67AQ47647029-CA5EBCD6-5D60-4F4E-B92D-54C3BB3465CCQ49848981-ACBEAB2C-DDCB-4EAE-9771-0D6E9964AB39Q53220585-48745B31-0088-433F-80EB-2C214798D146Q55069304-BD9527B4-5BCA-4F6B-80F7-7D6EAB06B88B
P2860
The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The Nationwide Austrian Asperg ...... /or immunosuppressed patients.
@ast
The Nationwide Austrian Asperg ...... /or immunosuppressed patients.
@en
type
label
The Nationwide Austrian Asperg ...... /or immunosuppressed patients.
@ast
The Nationwide Austrian Asperg ...... /or immunosuppressed patients.
@en
prefLabel
The Nationwide Austrian Asperg ...... /or immunosuppressed patients.
@ast
The Nationwide Austrian Asperg ...... /or immunosuppressed patients.
@en
P2093
P1476
The Nationwide Austrian Asperg ...... /or immunosuppressed patients.
@en
P2093
B Willinger
C Lass-Flörl
G Hartmann
J Auberger
M Girschikofsky
P304
P356
10.1016/J.IJANTIMICAG.2010.08.010
P577
2010-10-13T00:00:00Z